Cancer Screening Patient Matching Company
Here’s a breakdown of the key data from the provided text about mPATH Health and the CancerX Accelerator:
mPATH Health:
Founder & CEO: David P. Miller Jr., MD, MS, FACP
Focus: Increasing cancer screening rates, with plans to expand into HIV prevention and fertility preservation (especially for adolescents and young adults with cancer).
Mission: To find cancer early when it’s most treatable, saving lives. Current Status: Selected as one of 14 startups for the 2025 CancerX Accelerator cohort.
Contact: dave@mpathhealth.com
CancerX Accelerator:
Hosted by: Moffitt Cancer Center
Collaboration with: Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health.
Purpose: To support innovative digital health and AI startups addressing challenges in oncology.
Benefits for Startups:
Mentorship from healthcare leaders.
Product feedback.
Pilot opportunities.
Potential commercial agreements.
2026 Cohort Applications:
Open to CancerX members on sept. 2, 2025.
Open to the public on Sept. 9, 2025.
Community: https://cancerx.health/community/constellation
Healio’s Role:
Official Media Partner: Healio will cover breakthroughs and achievements from the 2025 and 2024 Accelerator cohorts.
In essence, the article highlights mPATH Health’s participation in a prestigious accelerator program designed to advance cancer care through technology and innovation.It also provides information about the CancerX Accelerator itself and how others can get involved.